Clinical Findings in Diabetes Mellitus Patients with COVID-19

Ting Guo,Qinxue Shen,Xiaoli Ouyang,Wei Guo,Jinhua Li,Wenlong He,Bo Yu,Chenfang Wu,Zhiguo Zhou,Hong Luo,Hong Peng
DOI: https://doi.org/10.1155/2021/7830136
IF: 4.0608
2021-01-08
Journal of Diabetes Research
Abstract:Backgrounds. Diabetes mellitus (DM) is one of the most common comorbidities in patients with coronavirus disease (COVID-19). We aim to summarize the clinical features of DM patients with COVID-19 and find out potential factors associated with severe disease. Methods. In this retrospective, single-center study, the medical records of patients with COVID-19 in Changsha, Hunan, China, from January 21, 2020, to February 19, 2020, were reviewed. Epidemiological information, clinical features, and outcomes were compared between DM patients admitted to the intensive care unit (ICU) or not. Results. A total of 241 patients confirmed with COVID-19 were enrolled, including 19 DM patients. There were more patients in DM group admitted to the ICU than non-DM group (36.8% vs. 15.8%, P = 0.045 ). Compared with non-DM group in the ICU, there were more female patients from DM group in the ICU (85.7% vs. 31.4%, P = 0.024 ). On admission, the mean level of glycated hemoglobin A1c (HbA1c) was higher in the ICU DM patients than that in the non-ICU DM patients (8.5% vs. 7.1%). There were more DM patients with proteinuria in the ICU group than the non-ICU group (57.1% vs. 33.3%). Twelve DM patients (63.2%) changed diabetic therapy during hospitalization, and all DM patients admitted to the ICU used insulin. As of March 14, all 19 DM patients have been discharged, and no death occurred. Conclusions. DM patients with COVID-19 are vulnerable to severe disease, especially for female patients. High levels of HbA1c and proteinuria could be potential risk factors for severe COVID-19 in DM patients. In addition to timely systemic therapy, the control of blood glucose and proper diabetic therapy is essential to improve the prognosis of severe DM patients with COVID-19.
endocrinology & metabolism,medicine, research & experimental
What problem does this paper attempt to address?
The problem this paper attempts to address is: What are the clinical characteristics and risk factors for severe disease in diabetic patients after being infected with the novel coronavirus (COVID-19)? Specifically, the researchers aim to summarize the clinical characteristics of diabetic patients with COVID-19 and identify potential factors associated with severe disease by retrospectively analyzing the medical records of 241 confirmed COVID-19 patients in Changsha, Hunan Province, from January 21 to February 19, 2020. ### Main Research Questions: 1. **What are the clinical manifestations and characteristics of diabetic patients after being infected with COVID-19?** 2. **What factors might make diabetic patients more likely to develop severe COVID-19?** ### Research Background: - Diabetes is one of the most common comorbidities among COVID-19 patients. - Diabetic patients are more likely to develop severe disease after being infected with COVID-19, requiring admission to the intensive care unit (ICU), mechanical ventilation, or even resulting in death. - However, there are few clinical studies on diabetic patients with COVID-19, and the related risk factors for severe disease are still unclear. ### Research Methods: - **Study Design**: Retrospective single-center study. - **Study Subjects**: 241 confirmed COVID-19 patients at the Public Health Clinical Center in Changsha, Hunan Province, from January 21 to February 19, 2020, including 19 diabetic patients. - **Data Collection**: Epidemiological information, clinical characteristics, and outcomes were collected from medical records. - **Group Comparison**: Patients were divided into diabetic and non-diabetic groups to compare differences between the two groups. The diabetic group was further divided into ICU and non-ICU patients to compare their clinical characteristics and laboratory results. ### Research Results: - **Overall Characteristics**: Diabetic patients were older and had more comorbidities, especially hypertension and coronary heart disease. - **Clinical Manifestations**: Diabetic patients had a higher incidence of proteinuria and higher levels of C-reactive protein upon admission. - **Severe Disease Risk**: The proportion of diabetic patients admitted to the ICU was significantly higher than that of non-diabetic patients (36.8% vs. 15.8%, P=0.045). The proportion of female diabetic patients in the ICU was higher (85.7% vs. 31.4%, P=0.024). - **Laboratory Tests**: Diabetic patients admitted to the ICU had higher levels of glycated hemoglobin (HbA1c) and a higher incidence of proteinuria. - **Treatment and Prognosis**: All diabetic patients admitted to the ICU received insulin therapy, and most diabetic patients adjusted their diabetes treatment regimen during hospitalization. All 19 diabetic patients recovered and were discharged, with no deaths. ### Conclusion: - Diabetic patients are more likely to develop severe disease after being infected with COVID-19, especially female patients. - High levels of HbA1c and proteinuria may be potential risk factors for severe COVID-19 in diabetic patients. - In addition to timely comprehensive treatment, controlling blood glucose and appropriate diabetes management are crucial for improving the prognosis of severe diabetic patients with COVID-19.